International Practice and Research in Haematology

Immunotherapy of minimal residual disease in conjunction with autologous and allogenic bone-marrow transplant; animal leukaemia models related to minimal residual disease; practical aspects of in-vitro manipulation of myeloid and lymphoid progenitors and the use of recombinant growth factors; application of PCR to the detection of minimal residual disease; immunological techniques for assessment of minimal residual disease; drug resistance mechanisms in leukaemia; mechanisms of the graft versus leukaemia cytokine mechanisms; autotransplantation in leukaemia; long-term marrow culture as a method of residual disease eradication.